Table 3.

Spearman rank correlation coefficients.

Gene/Network/Clinic	nM_M	O_T	EMT	Yoshihara
ABCB2/ABCB3/ABCC4/HER2	−0.01	0.02	0.08	−0.19
ABCC2	0.02	−0.01	−0.01	0.06
ESR1	−0.01	0.12	−0.12	−0.15
SLCO1B7	0.01	0.06	0.03	0.05
SLCO2A1	−0.16	0.02	−0.09	0.28
SLCO4C1	−0.08	0.12	0.04	−0.13
SLCO5A1	−0.09	−0.14	0.00	−0.13
Age	−0.13	0.04	0.01	0.12
FIGO	−0.01	−0.09	−0.17	0.04
Residual tumor	−0.06	0.02	0.04	0.12
ABCA1	−0.07	0.04	−0.13	0.21
ABCB1	−0.10	0.10	0.04	0.00
ABCC10	0.02	0.08	0.01	0.04
ESR2	−0.04	−0.05	−0.15	−0.26
HPGD	−0.18	0.08	−0.07	0.13
PTGS2	0.01	0.00	−0.12	0.05
PXR	−0.11	0.05	−0.02	−0.21
SLCO1A2	−0.22	−0.07	−0.10	−0.04
SLCO1B3	0.03	0.03	0.14	0.02
SLCO2B1/ABCC3	−0.05	0.11	−0.04	0.28
SLCO3A1	−0.10	0.13	−0.04	−0.08
SLCO4A1	0.07	0.10	0.19	−0.08
SLCO6A1	0.02	−0.08	−0.01	−0.03
SULT1E1	−0.06	0.11	−0.06	0.02

Data are given for (i) gene expressions, the first principal components of the co-expression networks, and clinicopathological parameters with (ii) gene signatures indicating molecular characteristics: peritoneal spread types, non-miliary or miliary (nM_M), positive value: high expression with M spreading; putative tumor origin, ovarian or fallopian tube (O_T), positive value: high expression with T origin; the epithelial-mesenchymal status (EMT), positive value: high expression with a more epithelial characteristic; and the Yoshihara (Yosh) molecular sub-classification system, high expression with subclass 2. Gray labeled are those genes, which were selected by the grouped LASSO approach predicting corresponding molecular characteristic. Bold printed are all genes/networks not present in any predictive LASSO regression model.